Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr11.80 DKK
Change Today +0.10 / 0.85%
Volume 104.8K
As of 11:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lars Kongsbak Ph.D.

Chief Executive Officer, President and Member of Executive Management Board,Exiqon A/S
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Lars Kongsbak, Ph.D. has been the Chief Executive Officer at Exiqon A/S since 2003. Dr. Kongsbak serves as President at Exiqon A/S and serves as its Member of the Executive Board. Prior to joining Exiqon, Dr. Kongsbak, was employed as Principal Scientist of Novo Nordisk, from 1995 to1997. He serves as founder and Managing Director of Kongsbak Invest ApS. Dr. Kongsbak held a staff scientist position at The Danish Technical University from 1992 to 1994 and did his ...

Read Full Background

Corporate Headquarters*

Skelstedet 16
Vedbæk, -- 2950


Phone: 45 45 66 08 88
Fax: 45 45 66 18 88

Board Members Memberships*



PhD 1990
Technical University of Denmark
MS 1988
Københavns Universitet

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr3,261,000

Stock Options*

Restricted Stock Awardskr2,570,000
All Other Compensationkr58,000

Total Compensation*

Total Annual Cash Compensationkr3,319,000
Total Short Term Compensationkr3,261,000
Other Long Term Compensationkr2,628,000
Total Calculated Compensationkr5,889,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXQ:DC kr11.80 DKK +0.10


Gajus V. Worthington Co-Founder, Chief Executive Officer and President
Fluidigm Corporation
Timothy B. Johnson Chief Executive Officer, President and Director
HTG Molecular Diagnostics, Inc.
Rolland D. Carlson Ph.D.Chief Executive Officer, President and Director
WaferGen Bio-systems, Inc.
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXIQON A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at